Bangor Savings Bank Amgen Inc Transaction History

Bangor Savings Bank

  • $1.06 Billion
  • Q4 2024

A detailed history of Bangor Savings Bank transactions in Amgen Inc stock. As of the latest transaction made, Bangor Savings Bank holds 6,278 shares of AMGN stock, worth $1.65 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
6,278
Previous 6,212 1.06%
Holding current value
$1.65 Million
Previous $2 Million 18.24%
% of portfolio
0.15%
Previous 0.19%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 07, 2025
BUY
$258.78 - $328.31 $17,079 - $21,668
66 Added 1.06%
6,278 $1.64 Million
Q3 2024

Oct 07, 2024
BUY
$309.38 - $337.38 $21,965 - $23,953
71 Added 1.16%
6,212 $2 Million
Q2 2024

Jul 15, 2024
BUY
$262.75 - $319.31 $5,780 - $7,024
22 Added 0.36%
6,141 $1.92 Million
Q1 2024

Apr 11, 2024
SELL
$268.87 - $324.56 $80,392 - $97,043
-299 Reduced 4.66%
6,119 $1.74 Million
Q4 2023

Jan 16, 2024
SELL
$255.7 - $288.46 $21,734 - $24,519
-85 Reduced 1.31%
6,418 $1.85 Million
Q3 2023

Oct 24, 2023
BUY
$218.65 - $271.46 $11,151 - $13,844
51 Added 0.79%
6,503 $1.75 Million
Q2 2023

Jul 07, 2023
BUY
$214.27 - $253.37 $31,497 - $37,245
147 Added 2.33%
6,452 $1.43 Million
Q1 2023

Apr 06, 2023
SELL
$225.79 - $275.2 $83,316 - $101,548
-369 Reduced 5.53%
6,305 $1.52 Million
Q4 2022

Jan 17, 2023
SELL
$229.03 - $291.01 $396,221 - $503,447
-1,730 Reduced 20.59%
6,674 $1.75 Million
Q3 2022

Oct 12, 2022
BUY
$224.46 - $253.15 $270,923 - $305,552
1,207 Added 16.77%
8,404 $1.89 Million
Q2 2022

Aug 15, 2022
BUY
$230.71 - $256.74 $1.66 Million - $1.85 Million
7,197 New
7,197 $1.75 Million
Q1 2022

Apr 14, 2022
SELL
$219.27 - $242.57 $1.33 Million - $1.47 Million
-6,058 Closed
0 $0
Q4 2021

Jan 20, 2022
BUY
$198.88 - $227.6 $184,361 - $210,985
927 Added 18.07%
6,058 $1.36 Million
Q3 2021

Oct 15, 2021
BUY
$212.27 - $248.7 $317,131 - $371,557
1,494 Added 41.08%
5,131 $1.09 Million
Q2 2021

Jul 23, 2021
BUY
$233.58 - $259.14 $21,489 - $23,840
92 Added 2.6%
3,637 $887,000
Q1 2021

Apr 20, 2021
BUY
$221.91 - $258.6 $58,584 - $68,270
264 Added 8.05%
3,545 $882,000
Q4 2020

Feb 09, 2021
SELL
$216.38 - $257.67 $17,310 - $20,613
-80 Reduced 2.38%
3,281 $754,000
Q4 2020

Jan 27, 2021
SELL
$216.38 - $257.67 $34,837 - $41,484
-161 Reduced 4.57%
3,361 $810,000
Q3 2020

Oct 06, 2020
BUY
$234.65 - $260.95 $81,188 - $90,288
346 Added 10.89%
3,522 $895,000
Q2 2020

Jul 08, 2020
SELL
$197.81 - $242.74 $26,110 - $32,041
-132 Reduced 3.99%
3,176 $749,000
Q1 2020

Apr 06, 2020
SELL
$182.24 - $241.7 $9,658 - $12,810
-53 Reduced 1.58%
3,308 $670,000
Q4 2019

Jan 07, 2020
BUY
$189.21 - $243.2 $7,946 - $10,214
42 Added 1.27%
3,361 $810,000
Q3 2019

Oct 07, 2019
BUY
$174.11 - $208.62 $105,684 - $126,632
607 Added 22.38%
3,319 $642,000
Q2 2019

Jul 08, 2019
BUY
$166.7 - $195.41 $5,001 - $5,862
30 Added 1.12%
2,712 $499,000
Q1 2019

Apr 08, 2019
BUY
$180.87 - $203.88 $9,947 - $11,213
55 Added 2.09%
2,682 $510,000
Q4 2018

Jan 17, 2019
SELL
$178.4 - $208.25 $32,112 - $37,485
-180 Reduced 6.41%
2,627 $511,000
Q3 2018

Oct 05, 2018
BUY
$185.29 - $208.89 $17,046 - $19,217
92 Added 3.39%
2,807 $582,000
Q2 2018

Jul 05, 2018
SELL
$166.05 - $186.51 $44,833 - $50,357
-270 Reduced 9.05%
2,715 $501,000
Q1 2018

Apr 23, 2018
SELL
$169.43 - $198.0 $8,810 - $10,296
-52 Reduced 1.71%
2,985 $509,000
Q4 2017

Apr 23, 2018
BUY
$168.79 - $188.59 $22,955 - $25,648
136 Added 4.69%
3,037 $528,000
Q3 2017

Nov 14, 2017
BUY
$167.29 - $191.0 $485,308 - $554,091
2,901
2,901 $540,000

Others Institutions Holding AMGN

# of Institutions
3,119
Shares Held
407M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $140B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Bangor Savings Bank Portfolio

Follow Bangor Savings Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bangor Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Bangor Savings Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email